Cash & equivalents decreased 48.4%
Cash & equivalents changed -48.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -48.4% from the comparable as-filed period.
Operating income changed +11.8% from the comparable as-filed period.
Operating margin changed +66 basis points from the comparable as-filed period.
Revenue changed +8.7% from the comparable as-filed period.
Net income changed +10.6% from the comparable as-filed period.
Research & development changed +14.5% from the comparable as-filed period.
Stock-based compensation changed +19.2% from the comparable as-filed period.
SBC / revenue changed +11 basis points from the comparable as-filed period.
Selling, general & administrative changed +8.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.